Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou

NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a leading innovator in microwave ablation (MWA) technology, continues to strengthen international medical collaboration. The Company recently hosted a delegation of distinguished Bangladeshi physicians at its Guangzhou headquarters for an expert-led MWA training program, further advancing global expertise in this cutting-edge treatment modality.

The delegation included Dr. MD Mofazzal Sharif, Dr. Mohammad Rezaul Haque, Dr. Alamgir A.B.M., and Dr. Mohammad Jannatul Ferdous Rubel, who participated in a comprehensive training program designed to enhance their expertise in MWA techniques. The program's first day featured in-depth theoretical discussions and hands-on demonstrations at Baird Medical's state-of-the-art facility, providing participants with a deeper understanding of MWA applications in clinical practice.

On the second day, the delegation continued their training with a visit to Sun Yat-sen University Cancer Center, where they were warmly welcomed by Dr. Fujun Zhang, Director of the Belt and Road Training Base of the Chinese Anti-Cancer Association. The visit began with the observation of multiple live MWA procedures, including liver and lung ablations. Following these observations, the delegation engaged in a comprehensive discussion, exchanging insights and best practices with leading specialists in the field. To conclude the day, the group participated in an in-depth session on thyroid microwave ablation techniques, led by Dr. Feng Han in the hospital's Ultrasound Department, further deepening their understanding of the latest advancements in MWA technology.

"This program exemplifies our commitment to global knowledge-sharing and medical innovation," said Haimei Wu, Chairwoman of Baird Medical. "By fostering cross-border collaboration, we aim to advance MWA technology and elevate patient care on a global scale."

Baird Medical remains dedicated to equipping medical professionals worldwide with cutting-edge expertise, reinforcing its role as a leader in the advancement of MWA technology.

About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.

These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.

Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in the United States, China, or other markets; (2) changes in economic, regulatory, or market conditions that impact Baird Medical's operations; (3) the ability to realize anticipated benefits from ongoing business initiatives or strategic transactions; (4) regulatory developments and compliance with applicable laws; (5) risks related to the development, commercialization, and market acceptance of Baird Medical's products; and (6) other risks and uncertainties detailed in Baird Medical's filings with the SEC.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.

Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-expands-global-mwa-training-with-expert-led-program-in-guangzhou-302385619.html

SOURCE BDMD